Hanne Beliën
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hanne Beliën has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Annelies Bronckaers
Hasselt University, Faculty of Medicine and Life Sciences, Biomedical Research Institute (BIOMED), Agoralaan, 3590 Diepenbeek, Belgium
2 shared publications - Lize Evens
UHasselt—Hasselt University, BIOMED—Biomedical Research Institute, Agoralaan, 3590 Diepenbeek, Belgium
2 shared publications - Marc Hendrikx
BIOMED, Hasselt University, Hasselt, Belgium; BIOMED, faculty medicine and life sciences, Hasselt, Belgium, Belgium
2 shared publications - Virginie Bito
Cardio & Organ Systems (COST), Biomedical Research Institute (BIOMED), Hasselt University, Agoralaan, 3590 Diepenbeek, Belgium
2 shared publications - Anny Steenwerckx
Orthopedic surgeon Jessa Hospital Hasselt Belgium
1 shared publication - Carl Dierickx
Orthopedic surgeon Jessa Hospital Hasselt Belgium
1 shared publication
Latest Publications
- 11 June 2021
- Published by Wiley in Medicinal Research Reviews
- Vol. 42 (1) , 343-373
Combining stem cells in myocardial infarction: The road to superior repair?
Myocardial infarction irreversibly destroys millions of cardiomyocytes in the ventricle, making it the leading cause of heart failure worldwide. Over the past two decades, many progenitor and stem cell types were proposed as the ideal candidate to regenerate the heart after injury. The potential of stem cell therapy has been investigated thoroughly in animal and human studies, aiming at cardiac repair by true tissue replacement, by immune modulation, or by the secretion of paracrine factors that stimulate endogenous repair processes. Despite some successful results in animal models, the outcome from clinical trials remains overall disappointing, largely due to the limited stem cell survival and retention after transplantation. Extensive interest was developed regarding the combinational use of stem cells and various priming strategies to improve the efficacy of regenerative cell therapy. In this review, we provide a critical discussion of the different stem cell types investigated in preclinical and clinical studies in the field of cardiac repair. Moreover, we give an update on the potential of stem cell combinations as well as preconditioning and explore the future promises of these novel regenerative strategies.
- 11 June 2021
- Published by Wiley in Medicinal Research Reviews
- Vol. 42 (1) , 343-373
Combining stem cells in myocardial infarction: The road to superior repair?
Myocardial infarction irreversibly destroys millions of cardiomyocytes in the ventricle, making it the leading cause of heart failure worldwide. Over the past two decades, many progenitor and stem cell types were proposed as the ideal candidate to regenerate the heart after injury. The potential of stem cell therapy has been investigated thoroughly in animal and human studies, aiming at cardiac repair by true tissue replacement, by immune modulation, or by the secretion of paracrine factors that stimulate endogenous repair processes. Despite some successful results in animal models, the outcome from clinical trials remains overall disappointing, largely due to the limited stem cell survival and retention after transplantation. Extensive interest was developed regarding the combinational use of stem cells and various priming strategies to improve the efficacy of regenerative cell therapy. In this review, we provide a critical discussion of the different stem cell types investigated in preclinical and clinical studies in the field of cardiac repair. Moreover, we give an update on the potential of stem cell combinations as well as preconditioning and explore the future promises of these novel regenerative strategies.
- Open Access
- 14 November 2020
- Published by Wiley in Stem Cells International
- Vol. 2020, 1-13
The Impact of Advanced Glycation End-Products (AGEs) on Proliferation and Apoptosis of Primary Stem Cells: A Systematic Review
Stem cell-based regenerative therapies hold great promises to treat a wide spectrum of diseases. However, stem cell engraftment and survival are still challenging due to an unfavorable transplantation environment. Advanced glycation end-products (AGEs) can contribute to the generation of these harmful conditions. AGEs are a heterogeneous group of glycated products, nonenzymatically formed when proteins and/or lipids become glycated and oxidized. Our typical Western diet as well as cigarettes contain high AGEs content. AGEs are also endogenously formed in our body and accumulate with senescence and in pathological situations. Whether AGEs have an impact on stem cell viability in regenerative medicine remains unclear, and research on the effect of AGEs on stem cell proliferation and apoptosis is still ongoing. Therefore, this systematic review provides a clear overview of the effects of glycated proteins on cell viability in various types of primary isolated stem cells used in regenerative medicine.
- 14 November 2020
- Published by Wiley in Stem Cells International
- Vol. 2020, 1-13
Open AccessThe Impact of Advanced Glycation End-Products (AGEs) on Proliferation and Apoptosis of Primary Stem Cells: A Systematic Review
Stem cell-based regenerative therapies hold great promises to treat a wide spectrum of diseases. However, stem cell engraftment and survival are still challenging due to an unfavorable transplantation environment. Advanced glycation end-products (AGEs) can contribute to the generation of these harmful conditions. AGEs are a heterogeneous group of glycated products, nonenzymatically formed when proteins and/or lipids become glycated and oxidized. Our typical Western diet as well as cigarettes contain high AGEs content. AGEs are also endogenously formed in our body and accumulate with senescence and in pathological situations. Whether AGEs have an impact on stem cell viability in regenerative medicine remains unclear, and research on the effect of AGEs on stem cell proliferation and apoptosis is still ongoing. Therefore, this systematic review provides a clear overview of the effects of glycated proteins on cell viability in various types of primary isolated stem cells used in regenerative medicine.
- Open Access
- 1 January 2017
- Published by Wiley in Journal of Experimental Orthopaedics
- Vol. 4 (1) , 1-10
Prebending of osteosynthesis plate using 3D printed models to treat symptomatic os acromiale and acromial fracture
Background: A symptomatic os acromiale can lead to impingement syndrome and rotator cuff tendinopathy. An acromion fracture is often part of a more complex scapular trauma that needs stabilisation.Methods: We developed a new technique using a three‐dimensional (3D) model and a distal clavicle reconstruction plate to treat os acromiale and acromion fractures. Our hypothesis was that such an approach would be a useful addition to the existing techniques. First, a 3D model of the acromion was printed, then an osteosynthesis plate was pre‐bent to fit the exact shape and curve of the acromion. We tested this technique and present reports on five patients, three with os acromiales and two with acromial fractures. We followed these patients during their rehabilitation and evaluated them using the Constant–Murley and the Disabilities of the Arm, Shoulder and Hand scores.Results: In every case the fracture or non‐union healed. If the surgery was performed before additional damage (such as an impingement syndrome) occurred, we saw that the patient’s pain completely disappeared. This new technique also has other advantages because the surgeon can prepare the entire operation in advance, which reduces the duration of surgery. Another advantage of using a 3D model is that it can also be used to inform the patient and the surgical team about the planned operation.Conclusion: This new technique using a preoperative patient‐customized plate is a good alternative for use in open reduction and internal fixation, particularly if the patient has no other conditions.
- 1 January 2017
- Published by Wiley in Journal of Experimental Orthopaedics
- Vol. 4 (1) , 1-10
Open AccessPrebending of osteosynthesis plate using 3D printed models to treat symptomatic os acromiale and acromial fracture
Background: A symptomatic os acromiale can lead to impingement syndrome and rotator cuff tendinopathy. An acromion fracture is often part of a more complex scapular trauma that needs stabilisation.Methods: We developed a new technique using a three‐dimensional (3D) model and a distal clavicle reconstruction plate to treat os acromiale and acromion fractures. Our hypothesis was that such an approach would be a useful addition to the existing techniques. First, a 3D model of the acromion was printed, then an osteosynthesis plate was pre‐bent to fit the exact shape and curve of the acromion. We tested this technique and present reports on five patients, three with os acromiales and two with acromial fractures. We followed these patients during their rehabilitation and evaluated them using the Constant–Murley and the Disabilities of the Arm, Shoulder and Hand scores.Results: In every case the fracture or non‐union healed. If the surgery was performed before additional damage (such as an impingement syndrome) occurred, we saw that the patient’s pain completely disappeared. This new technique also has other advantages because the surgeon can prepare the entire operation in advance, which reduces the duration of surgery. Another advantage of using a 3D model is that it can also be used to inform the patient and the surgical team about the planned operation.Conclusion: This new technique using a preoperative patient‐customized plate is a good alternative for use in open reduction and internal fixation, particularly if the patient has no other conditions.